Prometheus Biosciences
Utility Patents
Last updated:
List of all Prometheus Biosciences patents 7 in total
| Status | Patent |
|---|---|
Grant | Utility: Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A) Filling date: 6 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: GPR35 modulators Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Assays for detecting neutralizing autoantibodies to biologic therapy Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Methods for predicting post-operative recurrence of Crohn's disease Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Optimized anti-TL1A antibodies Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Methods for prediction of anti-TNF.alpha. drug levels and autoantibody formation Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Showing 1 to 7 of 7 patents.